Ann Hematol

1. SHI L, Yan X, Xia Y, Zhao Y, et al
   Beyond transfusions and transplants: genomic innovations rewriting the narrative of thalassemia.
   Ann Hematol. 2025;104:3963-3980.
   

   >> Share

   
   
2. OZAHATA MC, Gomes I, Oliveira BA, Park M, et al
   Genetic modifiers of frequent vaso-occlusive hospitalizations among individuals with sickle cell disease (SCD).
   Ann Hematol. 2025;104:4029-4035.
   

   >> Share

   
   
3. LI H, Gu Y, Zhao X, Ding G, et al
   Comparative longitudinal analysis of pulmonary function post-pediatric Allo-HSCT: benign vs. malignant diseases and early predictors.
   Ann Hematol. 2025;104:4201-4211.
   

   >> Share

   
   
4. WARNCKE K, Nero A, Sarode R, Adkins BD, et al
   Hyperhemolysis in a sickle cell disease patient in pregnancy.
   Ann Hematol. 2025;104:4245-4249.
   

   >> Share

   
   
5. PEDERSEN TH, Tjonnfjord E, Korkama ES, Vikman M, et al
   The incidence of paroxysmal nocturnal hemoglobinuria cell clones in the Nordic countries.
   Ann Hematol. 2025;104:4277-4283.
   

   >> Share

   
   
6. NIKOLAIDIS CG, Gyriki D, Gogos DG, Stavropoulou E, et al
   Sickle cell beta-thalassemia diagnosed at age 40: a case report.
   Ann Hematol. 2025;104:4229-4236.
   

   >> Share

   
   
7. WANG Y, Liu T, Wang W, Li Y, et al
   Three novel heterozygous ANK1 loss-of-function variants cause hereditary spherocytosis in Chinese families.
   Ann Hematol. 2025;104:4045-4056.
   

   >> Share

   
   

   
   Br J Haematol

8. LEUNG WY, Lee TY, Hwang YY, Lee JT, et al
   Iron overload and morbidities in Chinese with non-transfusion-dependent thalassaemia.
   Br J Haematol. 2025;207:1058-1069.
   

   >> Share

   
   
9. HAJJAJ OI, Callum J, Shehata N, Farrell A, et al
   Laboratory assessment of fetomaternal haemorrhage and Rh immune globulin management: Canadian practice and scoping review.
   Br J Haematol. 2025;207:723-736.
   

   >> Share

   
   
10. CHAMBLISS C, Manci E, Fields E, Bueno J, et al
    Characterizing pregnancy outcomes in a humanized mouse model of sickle cell disease.
    Br J Haematol. 2025;207:813-823.
    

    >> Share

    
    
11. SHANGGUAN S, Cui X, Li J, Li N, et al
    Alu-mediated FANCD2 exonic deletion contributes to Fanconi anaemia.
    Br J Haematol. 2025;207:1076-1084.
    

    >> Share

    
    
12. CHANG M, Semakula D, Little JA, Kanter J, et al
    Grandchildren of GRNDaD: Shifts in disease-modifying therapy at the adolescent transition in sickle cell disease.
    Br J Haematol. 2025;207:1070-1075.
    

    >> Share

    
    

    
    PLoS One

13. TETTEH DANQUAH A, Courtin D, Asamoah Sakyi S, Nakotey GK, et al
    HLA-G 14 bp polymorphism: Implications and its associated risk to malaria severity among iron-fortified Ghanaian infants and young children.
    PLoS One. 2025;20:e0322524.
    

    >> Share

    
    
14. CHULJERM H, Paradee N, Settakorn K, Srichairatanakool S, et al
    Pulsed electric field (PEF)-processed 6-shogaol-rich ginger extract protects beta-Thalassemic red blood cells from iron-induced oxidative stress and hemolysis.
    PLoS One. 2025;20:e0332386.
    

    >> Share

    
    
15. IBITOYE BM, Garrett B, Ranger M, Stinson JN, et al
    Adolescents' perspectives on non-pharmacological pain interventions for sickle cell crisis management: A population-based survey.
    PLoS One. 2025;20:e0330127.
    

    >> Share

    
    

    
    Transfusion

16. ALMAHMOUD K, Bauer S, Sherry C, Mancuso C, et al
    Provider uptake of the anemia protocol across different intensive care units over 5 years in urban medical center.
    Transfusion. 2025 Sep 17. doi: 10.1111/trf.18415.
    

    >> Share

    
    

    
    Transplant Proc

17. GUVEN AT, Comert KY, Mirzaevi E, Sayin CB, et al
    Clinical and Anemia-Related Predictors of Short-Term Mortality in Renal Transplantation Recipients After Graft Rejection: A Retrospective Study.
    Transplant Proc. 2025 Sep 16:S0041-1345(25)00448.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share